![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, January 11, 2024 1:27:45 PM
Think about this timeline....
GBB gets access to much of FSD Pharma's information surrounding its now named Unbuzzed drink, its formulation, and samples by signing an NDA and negotiating terms to be acquired by the FSD Pharma company, and within weeks of the agreement being drawn up but not executed, FSD Pharma ghosts GBB having determined that GBB is a bunch of stock fraud crooks, without any legitimate product or claims, where to be clear to the Market FSD Pharma comes out with a press release stating they have a new division that will develop, produce, and market an alcohol inebriation counter-effects drink.
Essentially, we should believe that GBB was able to create a new drink over 10 years for $100,000 where FSD Pharma has a whole team of world class scientists with state of the art scientific research facilities. And oh, GBB's access to the FSD Pharma drink and formulation had nothing to do with GBB's pump n dump selling a basic common energy drink without any ingredient that actually reduces blood alcohol content, or that lines the stomach to prevent alcohol absorption.
GBB is betting that between FSD Pharma's strong financial position and having a competitive product, where GBB first solicited FSD Pharma (not the other way around) GBB decided to act fast, go to market first, irrespective of having no legitimate product, but none the less to promote its stock fraud pump GBB provided the Market an appearance of GBB's legitimacy, GBB sued FSD Pharma to support its pump n dump stock fraud public facing story in order to run its $SHOT stock price much much higher, where insiders and their shells could and did unload most to all their sub-penny acquired $SHOT shares.
Big mistake!
© 2024, by StockItOut
Recent HUGE News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/13/2024 11:31:31 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/20/2024 11:01:57 AM
- GBB Maintains Strong Position in its Ongoing Lawsuit with FSD Pharma After Court Refuses to Dismiss Case • GlobeNewswire Inc. • 01/11/2024 06:10:23 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/05/2024 05:15:17 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM